Coronary artery disease genes and their mechanisms of mediating disease risk in the vascular wall

Description of the granted funding

Heart disease remains the number one cause of death in Finland and worldwide. Traditional risk factors, such as blood pressure, blood cholesterol and diabetes. are already effectively used in treatment of coronary artery disease (CAD). However, these risk factors can explain about a half of the risk for the coronary artery disease cases, and even less of the risk in fatal cases. Smooth muscle cells and endothelial cells, cell types located in the blood vessel walls, are important for the genetic risk of CAD. Based on large genetic studies, hundreds of genetics regions that are associated with heart disease, but we need to understand how these regions mediate the disease processes. I will investigate the the causal mechanisms and genes that mediate the disease using state-of the art methods: genome-wide CRISPR screens, AI-powered prioritization methods, in vivo-studies and vascular wall on chip modeling. This study may open new avenues to develop treatments to target blood vessels.
Show more

Starting year

2024

End year

2028

Granted funding

Markus Ramste Orcid -palvelun logo
256 515 €

Markus Otto Hjalmar Ramste Orcid -palvelun logo
256 515 €

Funder

Research Council of Finland

Funding instrument

Clinical researcher

Decision maker

Scientific Council for Biosciences, Health and the Environment
12.06.2024

Other information

Funding decision number

361054

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

cardiovascular diseases